Why Proof-of-Concept Non-GLP Studies Matter
A proof-of-concept non-GLP (Good Laboratory Practice) study is an early-stage research investigation designed to assess the feasibility and potential efficacy of a genetically modified animal model or compound. These studies are an inexpensive way to help confirm whether your concept is viable and ready for more rigorous and regulated testing.
The results of a proof-of-concept non-GLP study can confirm the basic premise of modifications to a genetically engineered animal or a genetically modified compound, and can help you avoid costly research and developmental risk before initiating full-scale discovery or safety assessment studies.
Preclinical Validation Breeds Confidence
Proof-of-concept non-GLP studies typically generate preliminary data critical for assessing the initial success of modifications, which can guide subsequent research. They are focused on early-stage research to explore the feasibility, efficacy, and potential safety of genetically modified models or compounds. In contrast, GLP-compliant studies are strictly regulated and adhere to specific guidelines to ensure that the data generated meets the requirements for regulatory submissions, such as those for clinical trials.
The baseline results of non-GLP studies will not only help guide your scientific premise, but you'll also have indicators of potential success to share with stakeholders. Data captured can include:
- Dosing: Precise administration of compounds to evaluate efficacy and safety
- Body Weights: Regular monitoring to assess health and growth parameters
- Blood and Tissue Collections: Comprehensive analysis of biological samples
- Glucose and Insulin Tolerance Tests: Assess metabolic function and disease models
- Tumor Measurements: Accurate assessment of tumor growth and response to treatments
- Special Diet and Water Administration: Customized nutritional regimens to support specific research needs
- External GFP Phenotype Checks: Visual confirmation of genetic modifications using GFP markers
Are Your Animals Housed at Charles River?
Leverage our expertise and infrastructure by partnering with our scientists and program managers. We will help you set up flexible, cost-effective, timely proof-of-concept studies to deliver critical, early-stage data. Talk to an Expert
Frequently Asked Questions (FAQs) About Proof-of-Concept Non-GLP Studies
-
Why should I conduct a proof-of-concept non-GLP study before moving to GLP-compliant studies?
Conducting a proof-of-concept non-GLP study allows you to validate the basic premise of your genetic modification or compound in a cost-effective manner. This helps mitigate the risk of failure in later, more expensive and strictly regulated GLP-compliant studies by identifying any potential issues early in the research process.
-
Can I conduct a proof-of-concept non-GLP study if my genetically modified animals are already housed at Charles River?
Yes. If your genetically modified strains are already housed at Charles River, you can leverage our facilities and expertise to conduct flexible, proof-of-concept non-GLP studies. This integration can streamline your research process and provide you with critical early-stage data without needing to transfer your animals to a different facility.
-
What level of customization is available for proof-of-concept non-GLP studies?
Our proof-of-concept non-GLP studies are highly customizable to meet your specific research needs. We offer a range of services, including tailored dosing regimens, specialized diets, custom phenotypic analyses, and more. Our team will work closely with you to design a study that aligns with your research goals and timelines.
-
How long does it typically take to complete a proof-of-concept non-GLP study?
The duration of a proof-of-concept non-GLP study can vary depending on the complexity of the genetic modifications or compounds being tested. However, these studies are generally designed to be completed in a shorter timeframe compared to GLP-compliant studies, allowing for rapid decision-making in the early stages of research.